Regulation of MAPK pathways in response to purinergic stimulation of adult rat cardiac myocytes

Molecular and Cellular Biochemistry

Volumn 242, Issue 1-2, 2003, Pages 163-171

  Markou, Thomais ^a   Vassort, Guy ^b   Lazou, Antigone ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

ERKs; Mitogen activated protein kinases; MSK1; p38 MAPK; Purinergic agonists; Rat cardiomyocytes

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYCLIC AMP DEPENDENT PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PHOSPHOLIPASE A2; PROTEIN KINASE C; PURINERGIC RECEPTOR STIMULATING AGENT; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

ANIMAL CELL; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HEART MUSCLE CELL; NONHUMAN; PROTEIN TARGETING; RAT; TIME; UPREGULATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; ENZYME ACTIVATION; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCYTES, CARDIAC; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOLIPASES A; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA;

ANIMALIA;

EID: 0037284343     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021110300652     Document Type: Article

References (35)

1. Vassort G: Adenosine 5′-triphosphate: A P2-purinergic agonist in the myocardium. Physiol Rev 81: 767-806, 2001
2. Legssyer A, Poggioli J, Renard D, Vassort G: ATP and the other adenine compounds increase mechanical activity mositol triphosphate production in rat heart. J Physiol 401: 185-199, 1988
3. Kuzmin AI, Lakomkin VL, Kapenko VI, Vassort G: Interstitial ATP level and degradation in control and postmyocardial infracted rats. Am J Physiol 275, C766-C771, 1998
4. Fredholm BB, Abbracchio MP, Burnstock G, Dubyak GR, Harden TK, Jacobson KA, Schwabe U, Williams M: Towards a revised nomenclature for P1 and P2 receptors. Trends Pharmacol Sci 18: 79-82, 1997
5. Ralevic V, Burnstock G: Receptors for purities and pyrimidines. Pharmacol Rev 50: 415-492, 1998
6. Communi D, Govaerts C, Parmentier M, Boeynaems JM: Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenyl cyclase. J Biol Chem 272: 31969-31973, 1997
7. Puceat M, Roche S, Vassort G: Src family tyrosine kinase regulates intracellular pH in cardiomyocytes. J Cell Biol 141: 1637-1646, 1998
8. TREK in cardiomyocytes. J Biol Chem 275: 39110-39116, 2000
9. 2. J Biol Chem 272: 16709-16712, 1997
10. Gijon MA, Leslie CC: Regulation of arachidonic acid release and cytosolic phospholipase A2 activation. J Leukoc Biol
11. Gijon MA, Spencer DM, Kaiser AL, Leslie CC: Role of phosphorylation sites and the C2 domain in regulation of cytosolic phospholipase A1. J Cell Biol 145: 1219-1232, 1999
12. Sugden PH, Clerk A: Cellular mechanisms of cardiac hypertrophy. J Mol Med 76: 725-746, 1998
13. Widmann C, Gibson S, Jarpe MB, Johnson GL: Mitogen-activated protein kinase: Conservation of a three kinase module from yeast to human. Physiol Rev 79: 143-180, 1999
14. Della Roca GJ, van Viesen T, Daaka Y, Luttrell DK, Luttrell LM, Lefkowitz RJ: Ras-dependent mitogen-activated protein kinase activation by G protein-coupled receptors. Convergence of Gi- and Gq-mediated pathways on calcium/calmodulin, Pyk2 and Src kinase. J Biol Chem 272: 19125-19132, 1997
15. 1-adrenergic agonists in adult rat hearts. Am J Physiol 267: H970-H978, 1994
16. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR: PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270: 27489-27494,1995
17. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, Trzaskos JM: Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273: 18623-18632, 1998
18. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F, Duhamel L, Charon D, Kirilovsky J: The bisindolylmaleimide GF109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266: 15771-15781, 1991
19. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter SW, Strickler JE, McLaughlin MM, Siemens IR, Fisher SM, Livi GP, White JR, Adams JL, Young PR: A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372: 739-746, 1994
20. Frantz B, Klatt T, Pang M, Parsons J, Rolando A, Williams H, Tocci MJ, O'Keefe SJ, O'Neill MA: The activation state of p38 mitogen-activated protein kinase determines the efficiency of ATP competition for pyridinylimidazole inhibitor binding. Biochemistry 37: 13846-13853, 1998
21. Yamboliev IA, Hedges JC, Mutnick JL, Adam LP, Gerthoffer WT: Evidence for modulation of smooth muscle force by the p38 MAP kinase/Hsp27 pathway. Am J Physiol 278: H1899-H1907, 2000
22. Deak M, Clifton AD, Lucocq JM, Alessi DR: Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38 andmaymediate activation of CREB. EMBO J 17:4426-4441, 1998
23. Hefner Y, Borsch-Haubold G, Murakami M, Wilde JI, Pasquet S, Schieltz, Ghomashchi F, Yates JR III, Armstrong CG, Paterson A, Cohen P, Fukunaga R, Hunter T, Kudi I, Watson SP, Gelb MH: Serine 7272 phosphorylation and activation of cytosolic phospholipase A2 by MNK1 -related protein kinases. J Biol Chem 275: 37542-37551, 2000
24. Antonysamy MA, Moticka EJ, Ramkurar V. Adenosine acts as an endogenous modulator of IL-2 dependent proliferation of cytotoxic T lymphocytes. J Immunol 15: 2813-2831, 1995
25. Abbracchio MP, Burnstock G: Purinergic signaling: Pathophysiological roles. Jpn J Pharmacol 78: 113-145, 1998
26. Zheng JS, Boluyt MO, O'Neil L, Crow MT, Lakatta EG: Extracellular ATP induces immediate-early gene expression but not cellular hypertrophy in neonatal cardiac myocytes. Circ Res 74: 1034-1041, 1994
27. Zheng JS, Boluyt MO, Long X, O'Neil L, Lakatta EG, Crow MT: Extracellular ATP inhibits adrenergic agonist-induced hypertrophy of neonatal cardiac myocytes. Circ Res 78: 525-535, 1996
28. Post GR, Goldstein D, Thuerauf DJ, Glembotski CC, Brown JH: Dissociation of p44 and p42 mitogen activated protein kinase activation from receptor-induced hypertrophy in neonatal rat ventricular myocytes. J Biol Chem 271: 8452-8457, 1996
29. Bogoyevitch MA, Glennon PE, Andersson MB, Clerk A, Lazou A, Marshall JC, Parker PJ, Sugden PH: Endothelin-1 and fibroblast growth factors stimulate the mitogen-activated protein kinase signaling cascade in cardiac myocytes. The potential role of the cascade in the integration of two signaling pathways leading to myocyte hypertrophy. J Biol Chem 269: 1110-1119, 1994
30. Clerk A, Michael A, Sugden PH: Stimulation of the p38 mitogen-activated protein kinase pathway in neonatal rat ventricular myocytes by the G protein-coupled receptor agonists, endothelin-1 and phenylephrine: A role in cardiac myocyte hypertrophy? J Cell Biol 142: 523-535, 1998
31. Puccat M, Bony C, Jaconi M, Vassort G: Specific activation of adenyl cyclase V by purinergic agonists. FEBS Lett 431: 189-194, 1998
32. 2 receptors stimulate mitogen-activated protein kinase in human embryonic kidney-293 cells. Cross-talk between camp and protein kinase C pathways. J Biol Chem 274: 5972-5980, 1999
33. Bogoyevitch MA, Marshall CJ, Sugden PH: Hypertrophic agonists stimulate the activities of the protein kinases c-Raf and A-Raf in cultured ventricular myocytes. J Biol Chem 270: 26303-26310, 1995
34. Thomson S, Clayton AL, Hazzalin CA, Rose S, Barrat MJ, Mahadevan LC: The nucleosomal response associated with immediate-early gene induction is mediated via alternative MAP kinase cascades: MSK1 as a potential histone H3/HMG-14 kinase. EMBO J 18: 4779-4793,1999
35. Arthur JSC, Cohen P: MSK1 is required for CREB phosphorylation in response to mitogens in mouse embryonic stem cells. FEBS Lett 482: 44-48, 2000